Abstract

Hepatocellular adenomas (HCA) are rare benign tumors. Women taking oral contraceptives (OC) represent the most classical circumstance of HCA appearance. In recent years, clinical diagnosis of focal nodular hyperplasia (FNH) vs HCA has significantly improved due to the wide use of contrast agent ultrasonography and magnetic resonance imaging (MRI). However, there are circumstances where the differential diagnosis remains difficult and consequently require specimen resection. In addition, the diagnosis of benign hepatocellular nodules has greatly benefited from the contribution of molecular biology [1–3] allowing for the differential diagnosis between FNH and HCA and the identification of HCA subtypes. To date three major subtypes have been identified: HNF1A mutated HCA (H-HCA), b-catenin mutated HCA (b-HCA), and inflammatory HCA (IHCA). IHCA can be also b-catenin mutated (b-IHCA). Less than 10% of HCA remain unclassified. A phenotypic classification of those benign tumors using immunohistochemistry has been derived from the above-mentioned molecular characterization. Liver fatty acid binding protein (LFABP), serum amyloid A (SAA)/C reactive protein (CRP), glutamine synthase (GS), and b-catenin immunohistochemical analyses performed on surgical specimens discriminate FNH from HCA and identify the different HCA subtypes (Table 1) [4–8]. The advantages of immunohistochemistry-based approaches are (i) simplicity (can be performed on formalin fixed, paraffin-embedded tissue), (ii) reproducibility and (iii) easiness to analyze (in most cases). Briefly, the use of molecular markers and its pathological counterparts has allowed (i) to clearly separate FNH from HCA by introducing the previously called telangiectatic FNH [9] in the subgroup of IHCA, (ii) to identify different clinical, biological, radiological, and pathological HCA subtypes andmost importantly (iii) to identify HCA at risk to malignant transformation

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.